Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 117,246 | 123,652 | 103,698 | 97,131 | 79,741 |
| Cost of Goods | 852 | 336 | 232 | 889 | N/A |
| Gross Profit | 116,394 | 123,316 | 103,466 | 96,242 | 79,741 |
| Operating Expenses | 54,104 | 55,764 | 49,397 | 47,093 | 38,092 |
| Operating Income | 63,142 | 67,888 | 54,301 | 50,038 | 41,649 |
| Other Income | 3,310 | 4,409 | 4,838 | 4,397 | 4,002 |
| Pre-tax Income | 66,452 | 72,297 | 59,139 | 54,435 | 45,651 |
| Income Tax | 25,252 | 27,703 | 20,699 | 19,052 | 15,978 |
| Net Income Continuous | 41,200 | 44,594 | 38,440 | 35,383 | 29,673 |
| Net Income | $41,200 | $44,594 | $38,440 | $35,383 | $29,673 |
| EPS Basic Total Ops | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 |
| EPS Basic Continuous Ops | 0.27 | 0.29 | 0.25 | 0.23 | 0.19 |
| EPS Diluted Total Ops | 0.24 | 0.26 | 0.22 | 0.20 | 0.17 |
| EPS Diluted Continuous Ops | 0.23 | 0.26 | 0.22 | 0.20 | 0.16 |
| EBITDA(a) | $66,242 | $70,758 | $57,047 | $52,686 | $43,541 |